Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
efficiently blocked this glycolipid antigen presentation both in vitro and in spinal cords of EAE mice
GBR-12935 is now widely used in animal research into Parkinson's disease and the dopamine pathways in the brain
with the potential for producing some of estrogen's beneficial effects without producing its adverse effects
Smiles: CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]21
CEP-33779 - CAS# 1257704-57-6 nshinone I efficiently blocked this glycolipid antigenCEP 33779 is a highly selective, orally active, small molecule inhibitor of JAK2. CEP 33779 induced regression of established colorectal tumors, reduced angiogenesis, and reduced proliferation of tumor cells. Tumor regression correlated with inhibition of STAT3 and NF B (RelA p65) activation in a CEP 33779 dose dependent manner. The ability of CEP 33779 to suppress growth of colorectal tumors by inhibiting the IL 6 JAK2 STAT3 signaling suggests a
US$ 607.50
US$ 848.00